Elon Musk’s brain implant startup, Neuralink, has secured $600 million in a recent funding round, pushing the company’s ...

Brad G. Smith, an ALS patient, regains communication abilities with a Neuralink implant, illustrating the potential of brain-computer interfaces in aiding speech impairments.

Reuters reports that Neuralink raised another $600 million in a deal that values the company at $9 billion before the ...

This summary encompasses various health-related developments, from halting drug trials after achieving success to geopolitical implications in vaccine production. Also covered are issues like measles ...

Cortigent is developing the Stroke Recovery System to improve the recovery of arm and hand movement in people who have suffered paralysis due to stroke Spin-off will allow Vivani to focus on its ...

Elon Musk has done it again. His brain-chip company Neuralink just raised $600 million at a $9 billion valuation, marking a ...

Neuralink last year received "breakthrough device" clearance from the U.S. FDA. Three people have so far received implants ...

Elon Musk's brain-mapping venture, Neuralink, recently raised $600 million, boosting its valuation to a staggering $9 billion ...

Elon Musk’s brain-implant company, Neuralink, has raised $600 million in a recent funding round, which pushed its pre-money valuation to $9 billion, according to Semafor. This latest round follows a ...

This briefing covers health-related developments worldwide, including Sanofi's vaccine initiatives in Vietnam, Roche's ...

(Reuters) - Elon Musk's brain implant company Neuralink raised $600 million at a valuation of $9 billion, Semafor reported on ...

The Washington Post: Billed As Nonaddictive, New Pain Pill Could Soon Win FDA Approval The long quest for powerful non-opioid drugs that treat pain without risk of addiction is nearing a milestone, in ...